Evidence map›Paper›PMID 16214886›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

p600, a unique protein required for membrane morphogenesis and cell survival.

Yoshihiro Nakatani, Hiroaki Konishi, Alex Vassilev, Hisanori Kurooka, Keiichiro Ishiguro, Jun-ichi Sawada, Tsuyoshi Ikura, Stanley J Korsmeyer, Jun Qin, Anna M Herlitz

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yoshihiro NakataniDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. nakatani@mac.com
Hiroaki Konishi
Alex Vassilev
Hisanori Kurooka
Keiichiro Ishiguro
Jun-ichi Sawada
Tsuyoshi Ikura
Stanley J Korsmeyer
Jun Qin
Anna M Herlitz
Harvard University · USNational Institutes of Health · USDana-Farber Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we identify and characterize p600, a unique 600-kDa retinoblastoma protein- and calmodulin-binding protein. In the nucleus, p600 and retinoblastoma protein seem to act as a chromatin scaffold. In the cytoplasm, p600 and clathrin form a meshwork structure, which could contribute to cytoskeletal organization and membrane morphogenesis. Reduced expression of p600 with interference RNA abrogates integrin-mediated ruffled membrane formation and, furthermore, prevents activation of integrin-mediated survival pathways. Consequently, knockdown of p600 sensitizes cells to apoptosis induced by cell detachment. These findings provide mechanistic insight into the regulation of membrane-proximal events in tumorigenesis.

Indexed as

Cell SurvivalApoptosisCalmodulinCalmodulin-Binding ProteinsCell MembraneCells, CulturedCell Surface ExtensionsCell Transformation, NeoplasticCytoskeletal ProteinsEnzyme ActivationFibroblastsHumansIntegrinsMolecular Sequence DataNuclear ProteinsProtein BindingCalmodulinCalmodulin-Binding ProteinsCytoskeletal ProteinsIntegrinsNuclear ProteinsRetinoblastoma ProteinUbiquitin-Protein LigasesUBR4 protein, human

Identifiers

PMID16214886
PMCPMC1247991
OpenAlexW2077335677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.